This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Merck Sharp & Dohme LLC, Merck Sharpe & Dohme Corp., Pfizer Corporation. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2020-2026
Title: Jamal Christo Tarazi: Innovator in Cancer Treatment
Introduction
Jamal Christo Tarazi is a notable inventor based in San Diego, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on combination therapies that target specific cancer pathways.
Latest Patents
Tarazi holds a patent for a groundbreaking invention titled "Combination of a PD-1 antagonist and a VEGFR inhibitor for treating cancer." This patent describes combination therapies that include an antagonist of the Programmed Death 1 receptor (PD-1) and a VEGFR inhibitor. The therapies are designed for the treatment of cancers that express PD-L1, showcasing Tarazi's commitment to advancing cancer treatment options. He has 1 patent to his name.
Career Highlights
Throughout his career, Tarazi has worked with prominent pharmaceutical companies, including Pfizer Corporation and Merck Sharp & Dohme Corp. His experience in these organizations has allowed him to contribute to significant advancements in medical research and drug development.
Collaborations
Tarazi has collaborated with esteemed colleagues in the field, including Jean-Francois Andre Martini and Rodolfo Fleury Perini. These partnerships have further enriched his research and innovation efforts.
Conclusion
Jamal Christo Tarazi is a dedicated inventor whose work in cancer treatment exemplifies the impact of innovative therapies in medicine. His contributions continue to pave the way for advancements in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile